Indevus Announces FDA Approval of Sanctura XR

Indevus Pharmaceuticals, Inc. announced that Sanctura XR (trospium chloride extended release capsules) has been approved by the U.S. Food and Drug Administration (FDA). Sanctura XR is indicated for the once- daily treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency.
Indevus